Celecoxibs farmakokinetik er ikke undersøgt hos patienter med nedsat nyrefunktion, men det er usandsynligt, at den er markant ændret hos disse patienter, idet elimineringen hovedsagelig sker ved levermetabolisme.
The pharmacokinetics of celecoxib has not been studied in patients with renal impairment but is unlikely to be markedly changed in these patients since it is mainly eliminated by hepatic metabolism.